Protein Biochips Market Trends

  • Report ID: 3257
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Protein Biochips Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Diabetes Prevalence- Protein biochips are used to measure level of glucose and other proteins in the blood. This can be used to detect early signs of diabetes, which is becoming increasingly common owing to changes in lifestyle and diet. Nearly 37.3 million Americans have diabetes according to the Centers for Disease Control and Prevention. Additionally, protein biochips can be used to monitor the progression of diabetes and to ensure that patients are receiving proper treatment.

  • Intensified Funding for Pharmaceutical R&D Activities Across the Globe- A wide range of activities were covered by the costs, including medication research and testing, incremental enhancements, or expansions of products, and medical studies to monitor their safety. For instance, the US pharmaceutical companies spent more than USD 85 billion on research and development in 2019.
  • Rapid Emergence of Next-Generation Sequencing- The Next-Generation Sequencing NGS technology has revolutionized genomic research with its high throughput capabilities. Thousands to millions of molecules can be sequenced simultaneously using NGS methods as they are highly parallelized. Protein biochips are used to capture and analyze proteins in a sample. By analyzing the proteins, researchers can gain insights into the biological processes taking place within the sample. This makes it a valuable tool for Next-Generation Sequencing NGS which seeks to analyse a large number of samples quickly and efficiently.

Challenges

  • The Shortage of Experienced Professionals for Developing and Operating Protein Biochip- The Technology's complexity and the necessity of it highly specialized knowledge and skills to develop and operate protein biochips makes it difficult to find the right people with the necessary skills. That's making things difficult. Companies want to use the technology more widely. It also restricts the growth possibilities of the market.

  • Biochips are Expensive to Produce

  • Lack of Understanding Between People on the Subject Use of Protein Biochips for Potential Benefits


Base Year

2024

Forecast Year

2025-2037

CAGR

15.2%

Base Year Market Size (2024)

USD 9.22 billion

Forecast Year Market Size (2037)

USD 58.02 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of protein biochips is evaluated at USD 10.41 billion.

The protein biochips market size was valued at USD 9.22 billion in 2024 and is expected to reach USD 58.02 billion by 2037, registering around 15.2% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of chronic diseases and the growing demand for personalized medicine will fuel the market growth.

North America industry is estimated to dominate majority revenue share of 38% by 2037, backed by growing awareness among healthcare professionals regarding the various advantages associated with protein biochips in the region.

The major players in the market are Dynamic Biosensors GmbH, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., ABTECH Scientific, Inc., Standard BioTools Inc., Merck KGaA, LI-COR, Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos